New approach to septal ablation: Glue (cyanoacrylate) septal ablation

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 7, 2007, Pages 1021-1025

  Oto, Ali ^a   Aytemir, Kudret ^a   Deniz, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cyanoacrylate; Hypertrophic obstructive cardiomyopathy; Septal ablation

Indexed keywords

CYANOACRYLATE; IODINATED POPPYSEED OIL;

ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CASE REPORT; CATHETER ABLATION; CORONARY ARTERY ANOMALY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CYANOACRYLATES; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART SEPTUM; HUMANS; MALE; RADIOGRAPHY, INTERVENTIONAL; TREATMENT OUTCOME;

EID: 34250175773     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21003     Document Type: Article

References (14)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
2. Holmes DR, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique. Catheter Cardiovasc Interv 2005;66:375-389.
3. Pollak JS, White RI. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 2001;12:907-913.
4. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 1997;95:2075-2081.
5. Perez MA, Valenzuela GM, Blanes JG, et al. Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy. Rev Esp Cardiol 2005;58:872-874.
6. Aroney CN, Goh TH, Hourigan LA, et al. Ventricular septal rupture following nonsurgical septal reduction for hypertrophic cardiomyopathy: Treatment with percutaneous closure. Catheter Cardivasc Interv 2004;61:411-414.
7. Agarwal SC, Purcell IF, Furniss SS. Apical myocardial injury caused by collateralization of a septal artery during ethanol septal ablation. Heart 2005;91:e2.
8. Raute-Kreinsen U. Morphology of necrosis and repair after transcoronary ethanol ablation of septal hypertrophy. Pathol Res Pract 2003;199:121-127.
9. Cotran RS, Kumar V,Collins T, editors. Robbins Pathologic Basis of Disease,6th ed. Philadelphia, PA: Sounders; 1999. p 558.
10. Oomman A, Ramachandran P, Subramanyan K, et al. Transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results. J Invasive Cardiol 2001;13:526-530.
11. Gaspar J, Martinez-Rios M, Vonderwalde C, et al. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv 1999;47: 73-79.
12. Uhlrich F, Waigand J, Gross CM, et al. Transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy: Embolization with particles instead of alcohol. Am J Cardiol 1999;84 (Suppl 6A):123P.
13. Iacob M, Pinte F, Tintoiu I, et al. Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Pol Heart J 2004;61:10.
14. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute result and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-258.